Recent Finacing
Recent Raise
Mapi Pharma is a clinical-stage biopharmaceutical developing long-acting glatiramer acetate depot injections for multiple sclerosis, focused on lifecycle-management, with R&D in Israel and an API facility in Neot Hovav.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Mapi Pharma.
